XML 57 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Teva Agreement (Details Textual)
1 Months Ended 9 Months Ended 12 Months Ended 1 Months Ended
Nov. 30, 2012
USD ($)
Mar. 16, 2011
USD ($)
Jan. 31, 2014
USD ($)
Jan. 31, 2013
USD ($)
Apr. 30, 2013
CAD
Mar. 16, 2011
One Compound [Member]
USD ($)
Mar. 16, 2011
Second Compound [Member]
USD ($)
Potential Milestone Payments   $ 27,000,000          
Royalty Expense         10,000 460,000 880,000
Exercise of Options to One Time Royalty Fee 880,000   880,000        
Deferred Revenue, Revenue Recognized     133,000 317,000      
Increase (Decrease) in Contract Receivables, Net     $ 277,000